Gaibar, M.Novillo, A.Romero-Lorca, A.Esteban i Torné, Maria EstherFernández-Santander, A.2019-05-212019-05-212018-07-311470-269Xhttps://hdl.handle.net/2445/133582Cytochrome P450 (CYP450), sulfotransferase (SULT), and glucuronidase (UGT) enzymes play roles in the phase I and phase II metabolism of most clinically prescribed drugs. As polymorphisms in these genes may alter enzyme activities, most prescribed drugs will differ in their efficacy and side effects. In prior work, we showed that besides polymorphisms in CYP450, those in SULT and UGT also give rise to different serum levels of some drug metabolites than detected in wild-type carriers of the genes [1]. [...]4 p.application/pdfengcc by (c) Gaibar, M. et al., 2018http://creativecommons.org/licenses/by/3.0/es/EnzimsÀfrica del NordFarmacogenèticaEnzymesNorth AfricaPharmacogeneticsinfo:eu-repo/semantics/article6820372019-05-21info:eu-repo/semantics/openAccess